ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 248,66
0,75%
Dow Jones
39 387,76
0,85%
DAX
18 789,53
0,59%
Brent Oil
84,255
0,36%
Bitcoin
62 886,79
-0,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alector Inc (ALEC)

  7. Alector Inc (ALEC) Actualités

ALEC

Alector (ALEC)

Alector Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALEC
DateHeureSourceTitreSymboleSociété
09/05/202413h00GlobeNewswire Inc.Alector to Participate in Upcoming Healthcare ConferencesNASDAQ:ALECAlector Inc
08/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALECAlector Inc
08/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALECAlector Inc
08/05/202422h05GlobeNewswire Inc.Alector Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ALECAlector Inc
06/03/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALECAlector Inc
02/03/202401h52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALECAlector Inc
27/02/202422h41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALECAlector Inc
27/02/202422h05GlobeNewswire Inc.Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ALECAlector Inc
20/02/202422h05GlobeNewswire Inc.Alector to Host Fourth Quarter and Full-Year 2023 Earnings CallNASDAQ:ALECAlector Inc
09/02/202400h59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ALECAlector Inc
08/02/202413h00GlobeNewswire Inc.Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s DiseaseNASDAQ:ALECAlector Inc
07/02/202413h00GlobeNewswire Inc.FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NASDAQ:ALECAlector Inc
19/01/202415h20GlobeNewswire Inc.Alector Announces Closing of Public OfferingNASDAQ:ALECAlector Inc
19/01/202412h04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALECAlector Inc
17/01/202414h54GlobeNewswire Inc.Alector Announces Pricing of Public Offering of Common StockNASDAQ:ALECAlector Inc
16/01/202422h01GlobeNewswire Inc.Alector Announces Proposed Public Offering of Common StockNASDAQ:ALECAlector Inc
28/11/202313h00GlobeNewswire Inc.Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin ProgramsNASDAQ:ALECAlector Inc
08/11/202313h00GlobeNewswire Inc.Alector to Participate in the Stifel Healthcare ConferenceNASDAQ:ALECAlector Inc
07/11/202322h05GlobeNewswire Inc.Alector Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ALECAlector Inc
27/10/202313h00GlobeNewswire Inc.Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)NASDAQ:ALECAlector Inc
07/09/202313h00GlobeNewswire Inc.Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s DiseaseNASDAQ:ALECAlector Inc
03/08/202322h05GlobeNewswire Inc.Alector Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ALECAlector Inc
27/07/202314h30GlobeNewswire Inc.Alector to Host Mid-Year Earnings Conference CallNASDAQ:ALECAlector Inc
15/06/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALECAlector Inc
15/06/202322h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALECAlector Inc
06/06/202313h00GlobeNewswire Inc.Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:ALECAlector Inc
02/06/202301h35Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ALECAlector Inc
04/05/202322h20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALECAlector Inc
04/05/202322h05GlobeNewswire Inc.Alector Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ALECAlector Inc
02/05/202314h31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ALECAlector Inc
 Showing the most relevant articles for your search:NASDAQ:ALEC

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
AI
Air Liquide
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
EU
BN
Danone
NYSE
MCD
McDonalds
EU
DG
Vinci
EU
VK
Vallourec
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
EU
GLE
Societe Generale
NASDAQ
MSFT
Microsoft
NYSE
KO
Coca Cola
NASDAQ
AAPL
Apple
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés